Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nuclein logo — Simple, affordable, rapid, and accurate testing for everyone...

Nuclein

Simple, affordable, rapid, and accurate testing for everyone.

Founded 2017 United States Austin, United States 50 employees Debt Financing Biotechnology, Health Care +1

General Information

Company Name Nuclein
Founded Year 2017
Location United States Austin, United States
Employees 50
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Nuclein. To contact Nuclein, visit nuclein.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nuclein compare?

A PDF of Nuclein and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nuclein soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nuclein

Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone. Its DASH® Rapid PCR System runs the FDA-cleared and CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test and delivers lab-quality, point-of-care PCR results in 15 minutes. With a speed that is typically only available with antigen tests, the DASH® Rapid PCR System was designed to offer low-cost, sensitive and specific results, with robust multiplexing across various sample types, and requires less than one minute of hands-on time. Nuclein has raised approximately $50 million to date, led by private equity firm Trinity Investors. In 2023, Nuclein merged with Minute Molecular Diagnostics, Inc., a Northwestern University spin-out that initially developed the DASH System.

No funding data available for Nuclein yet.

FAQ About Nuclein

Simple, affordable, rapid, and accurate testing for everyone.
Nuclein was founded in 2017.
Nuclein is headquartered in Austin, United States.
Nuclein operates in Biotechnology, Health Care and Medical Devices.
Nuclein has approximately 50 employees.

We're actively collecting intelligence on Nuclein.

Source: BounceWatch company record for Nuclein, https://bouncewatch.com/company/nuclein, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes